Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction

Aim. This study aims to investigate the effect of senile asthenia syndrome (SAS) on the cardiovascular mortality risk within 12 months in patients over 70 years of age with myocardial infarction.Material and methods. We performed a retrospective study of 92 patients over 70 years of age with myocard...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Aydumova, Yu. V. Shchukin, M. V. Piskunov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-07-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5391
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849341312750321664
author O. Yu. Aydumova
Yu. V. Shchukin
M. V. Piskunov
author_facet O. Yu. Aydumova
Yu. V. Shchukin
M. V. Piskunov
author_sort O. Yu. Aydumova
collection DOAJ
description Aim. This study aims to investigate the effect of senile asthenia syndrome (SAS) on the cardiovascular mortality risk within 12 months in patients over 70 years of age with myocardial infarction.Material and methods. We performed a retrospective study of 92 patients over 70 years of age with myocardial infarction, who agreed to participate. To detect senile asthenia syndrome, we used the questionnaire "Age is not a hindrance". We estimated the anamnestic data, and also laboratory and instrumental parameters. The follow-up period was 12 months. As an end-point, the onset of an adverse event — cardiovascular death was chosen. Statistical nonparametric methods, ROC analysis, Kaplan-Meier survival analysis (p<0,05) were used.Results. In 12 months, 19 patients (20,65%) met the end-point. The median (25%; 75%-quartile) of the numbers of points according to the questionnaire "Age is not a hindrance" was significantly higher in the group of dead patients than in the group without adverse outcomes — 4 (3; 5) and 2 (1; 4) points (p<0,001). When gaining 3 or more points according to the questionnaire "Age is not a hindrance", risk ratio of cardiovascular death within 12 months was 1,72; 95% confidence interval: 1,28-2,30 (p=0,001). In conduction of ROC analysis to predict adverse outcome when gaining 3 or more points according to the questionnaire "Age is not a hindrance", the area under the curve (AUC) was 0,78 (p<0,001), sensitivity — 89%, specificity — 60%.Conclusion. The risk of cardiovascular death within 12 months after myocardial infarction in patients over 70 years of age with SAS increases by 72%. The inclusion of the results from the questionnaire "Age is not a hindrance" into prognostic models, and the SAS estimation in this cohort of patients will improve the risk stratification.
format Article
id doaj-art-81b3b7cf2fa34587803ad1f22011664d
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2023-07-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-81b3b7cf2fa34587803ad1f22011664d2025-08-20T03:43:40Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-07-01282S10.15829/1560-4071-2023-53913840Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarctionO. Yu. Aydumova0Yu. V. Shchukin1M. V. Piskunov2Samara State Medical UniversitySamara State Medical UniversityFederal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Health of the Russian FederationAim. This study aims to investigate the effect of senile asthenia syndrome (SAS) on the cardiovascular mortality risk within 12 months in patients over 70 years of age with myocardial infarction.Material and methods. We performed a retrospective study of 92 patients over 70 years of age with myocardial infarction, who agreed to participate. To detect senile asthenia syndrome, we used the questionnaire "Age is not a hindrance". We estimated the anamnestic data, and also laboratory and instrumental parameters. The follow-up period was 12 months. As an end-point, the onset of an adverse event — cardiovascular death was chosen. Statistical nonparametric methods, ROC analysis, Kaplan-Meier survival analysis (p<0,05) were used.Results. In 12 months, 19 patients (20,65%) met the end-point. The median (25%; 75%-quartile) of the numbers of points according to the questionnaire "Age is not a hindrance" was significantly higher in the group of dead patients than in the group without adverse outcomes — 4 (3; 5) and 2 (1; 4) points (p<0,001). When gaining 3 or more points according to the questionnaire "Age is not a hindrance", risk ratio of cardiovascular death within 12 months was 1,72; 95% confidence interval: 1,28-2,30 (p=0,001). In conduction of ROC analysis to predict adverse outcome when gaining 3 or more points according to the questionnaire "Age is not a hindrance", the area under the curve (AUC) was 0,78 (p<0,001), sensitivity — 89%, specificity — 60%.Conclusion. The risk of cardiovascular death within 12 months after myocardial infarction in patients over 70 years of age with SAS increases by 72%. The inclusion of the results from the questionnaire "Age is not a hindrance" into prognostic models, and the SAS estimation in this cohort of patients will improve the risk stratification.https://russjcardiol.elpub.ru/jour/article/view/5391myocardial infarctionsenile asthenia syndromefrailty syndromemedium-term forecastcardiovascular death
spellingShingle O. Yu. Aydumova
Yu. V. Shchukin
M. V. Piskunov
Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
Российский кардиологический журнал
myocardial infarction
senile asthenia syndrome
frailty syndrome
medium-term forecast
cardiovascular death
title Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
title_full Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
title_fullStr Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
title_full_unstemmed Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
title_short Effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
title_sort effect of senile asthenia syndrome on cardiovascular mortality within 12 months in patients over 70 years of age with myocardial infarction
topic myocardial infarction
senile asthenia syndrome
frailty syndrome
medium-term forecast
cardiovascular death
url https://russjcardiol.elpub.ru/jour/article/view/5391
work_keys_str_mv AT oyuaydumova effectofsenileastheniasyndromeoncardiovascularmortalitywithin12monthsinpatientsover70yearsofagewithmyocardialinfarction
AT yuvshchukin effectofsenileastheniasyndromeoncardiovascularmortalitywithin12monthsinpatientsover70yearsofagewithmyocardialinfarction
AT mvpiskunov effectofsenileastheniasyndromeoncardiovascularmortalitywithin12monthsinpatientsover70yearsofagewithmyocardialinfarction